Literature DB >> 25456681

[Streptococcus pyogenes pathogenic factors].

Ph Bidet1, S Bonacorsi2.   

Abstract

The pathogenicity of ß-hemolytic group A streptococcus (GAS) is particularly diverse, ranging from mild infections, such as pharyngitis or impetigo, to potentially debilitating poststreptococcal diseases, and up to severe invasive infections such as necrotizing fasciitis or the dreaded streptococcal toxic shock syndrome. This variety of clinical expressions, often radically different in individuals infected with the same strain, results from a complex interaction between the bacterial virulence factors, the mode of infection and the immune system of the host. Advances in comparative genomics have led to a better understanding of how, following this confrontation, GAS adapts to the immune system's pressure, either peacefully by reducing the expression of certain virulence factors to achieve an asymptomatic carriage, or on the contrary, by overexpressing them disproportionately, resulting in the most severe forms of invasive infection.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25456681     DOI: 10.1016/S0929-693X(14)72261-4

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Genomic analysis of a Streptococcus pyogenes strain causing endocarditis in a child.

Authors:  M Beye; K El Karkouri; N Labas; D Raoult; P-E Fournier
Journal:  New Microbes New Infect       Date:  2017-01-28

2.  Mitral Valve Infective Endocarditis due to Streptococcus pyogenes: A Case Report.

Authors:  Cristina Sarda; Giulia Magrini; Sfefano Pelenghi; Annalisa Turco; Elena Seminari
Journal:  Cureus       Date:  2019-04-15

3.  A case report of hemolytic streptococcal gangrene in the danger triangle of the face with thrombocytopenia and hepatitis.

Authors:  Xiao-Ling Jia; Janak L Pathak; Jin-Fa Tong; Ji-Mei Su
Journal:  BMC Pediatr       Date:  2018-06-22       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.